Obesity market to reach $173.5 billion sales in 7MM by 2031, forecasts GlobalData
Growing patient awareness and emerging therapies drive obesity drug market expansion across the US, Europe, and Japan
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
obesity market
Eli Lilly’s Zepbound holds possibility to dominate obesity market
Recently, Eli Lilly announced the results from its SURMOUNT-5 trial, comparing Zepbound and Wegovy’s efficacy on equal grounds
Viking Therapeutics’ obesity drug could become direct competitor to Eli Lilly’s tirzepatide:…
With promising Phase IIa results and a dual GLP-1/GIP receptor mechanism, VK2735 could soon compete directly with tirzepatide in…
Obesity market across 7MM set to surpass $37 bn in 2031: GlobalData
Drivers will be the launch of therapies with promising efficacies and/or new routes of administration, as well as the growth of…